Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Gene may fend off prions

15.11.2001


Part of a prion, the protein implicated in vCJD
© SPL


A gene may protect people against variant Creutzfeldt-Jakob disease.

People who lack a gene involved in immune responses may be three times more likely to suffer from variant Creutzfeldt-Jakob disease (vCJD), a new study suggests1. The result, if borne out in larger studies, could point researchers toward therapies for the incurable brain disease.

vCJD is thought to occur when people are exposed to misshapen prion proteins from cows with bovine spongiform encephalopathy - BSE or ’mad cow disease’. The gene does not appear to protect against the sporadic form of the disease (CJD).



Of 50 patients with vCJD - about half of those known to have the disease - only 12% have a gene called DQ7, John Collinge of Imperial College School of Medicine in London and his colleagues have found. In contrast, 36% of the normal population has the gene.

The small number of participants makes it difficult to draw conclusions from the study, experts warn. "These kinds of studies are very susceptible to false positive findings," says Cornelia van Duijn, a genetic epidemiologist at Erasmus University Medical School in Rotterdam.

But, by shedding light on susceptibility to the disease, the study could improve estimates of how many people will develop it, van Duijn adds.

It would take something like 500 patients - many more than have been diagnosed - to get truly reliable findings, says Stephen O’Brien, a geneticist at that US National Cancer Institute in Maryland. Nonetheless, he says, "the results are provocative and make us want to know if they’re right".

It would be good to test a larger sample, agrees Collinge.

Although the findings do not point to any immediate therapy for the disease they could help researchers looking for treatments. "If we can understand why DQ7 is important in protecting against vCJD, it might open up new avenues to treatment," Collinge says.

References

  1. Jackson, G. S. et al. HLA-DQ7 antigen and resistance to variant CJD. Nature, 414, 269 - 270, (2001).


ERICA KLARREICH | © Nature News Service
Further information:
http://www.nature.com/nsu/

More articles from Health and Medicine:

nachricht Purdue cancer identity technology makes it easier to find a tumor's 'address'
16.11.2018 | Purdue University

nachricht Microgel powder fights infection and helps wounds heal
14.11.2018 | Michigan Technological University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: UNH scientists help provide first-ever views of elusive energy explosion

Researchers at the University of New Hampshire have captured a difficult-to-view singular event involving "magnetic reconnection"--the process by which sparse particles and energy around Earth collide producing a quick but mighty explosion--in the Earth's magnetotail, the magnetic environment that trails behind the planet.

Magnetic reconnection has remained a bit of a mystery to scientists. They know it exists and have documented the effects that the energy explosions can...

Im Focus: A Chip with Blood Vessels

Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.

Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

Im Focus: Research icebreaker Polarstern begins the Antarctic season

What does it look like below the ice shelf of the calved massive iceberg A68?

On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.

Im Focus: Penn engineers develop ultrathin, ultralight 'nanocardboard'

When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure

Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

European Space Talks: Weltraumschrott – eine Gefahr für die Gesellschaft?

23.10.2018 | Event News

 
Latest News

Purdue cancer identity technology makes it easier to find a tumor's 'address'

16.11.2018 | Health and Medicine

Good preparation is half the digestion

16.11.2018 | Life Sciences

Microscope measures muscle weakness

16.11.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>